U.S. flag

An official website of the United States government

NM_005188.4(CBL):c.1237G>C (p.Gly413Arg) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 16, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000376659.1

Allele description [Variation Report for NM_005188.4(CBL):c.1237G>C (p.Gly413Arg)]

NM_005188.4(CBL):c.1237G>C (p.Gly413Arg)

Gene:
CBL:Cbl proto-oncogene [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q23.3
Genomic location:
Preferred name:
NM_005188.4(CBL):c.1237G>C (p.Gly413Arg)
HGVS:
  • NC_000011.10:g.119278519G>C
  • NG_016808.1:g.77240G>C
  • NM_005188.4:c.1237G>CMANE SELECT
  • NP_005179.2:p.Gly413Arg
  • LRG_608:g.77240G>C
  • NC_000011.9:g.119149229G>C
  • NM_005188.2:c.1237G>C
Protein change:
G413R
Links:
dbSNP: rs371679886
NCBI 1000 Genomes Browser:
rs371679886
Molecular consequence:
  • NM_005188.4:c.1237G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000330527GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Feb 16, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000330527.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The G413R variant in the CBL gene has not, to our knowledge, been published in the literature as a germline variant; however, it has been reported as a somatic variant in lung carcinoma samples according to the Catalogue of Somatic Mutations in Cancer (COSMIC) database. The G413R variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G413R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution is located within the RING-type zinc finger domain and occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (W408R, F418S, F418L) have been reported in the Human Gene Mutation Database in association with CBL-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, we interpret G413R as a likely pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 12, 2024